NantHealth shares soar 36% in market debut

Shares of NantHealth Inc. were up 36% in the biotech company’s market debut on the Nasdaq Thursday. Shares were trading around $19 in midday trade, above the company’s $14 issue price. The company sold 6.5 million shares to raise $91 million. Jefferies LLC and Cowen and Company, LLC acted as the lead underwriters.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

NantHealth shares soar 36% in market debut

Shares of NantHealth Inc. were up 36% in the biotech company’s market debut on the Nasdaq Thursday. Shares were trading around $19 in midday trade, above the company’s $14 issue price. The company sold 6.5 million shares to raise $91 million. Jefferies LLC and Cowen and Company, LLC acted as the lead underwriters.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Signet Jewelers shares fall after concerns raised about credit operations, gem quality

Signet Jewelers Ltd. shares are down 7.1% in Thursday trading after reports that an investment newsletter raised questions about the company’s credit operations and gem quality. Signet did not immediately respond to a request for comment. In its fiscal first-quarter report released last month, Signet said it has hired Goldman Sachs as a financial advisor as it conducts a strategic evaluation of its credit portfolio. Signet shares are down nearly 26% for the year to date while the S&P 500 is up 2.5% for the same period.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Oil pares losses after EIA reports 1.4 million-barrel fall in U.S. crude supplies

Oil futures pared some of their earlier losses Thursday after the U.S. Energy Information Administration reported that U.S. crude supplies fell by 1.4 million barrels for the week ended May 27. The American Petroleum Institute late Wednesday had reported a 2.4 million-barrel rise, while analysts polled by S&P Global Platts expected a 3.1 million-barrel decline. Gasoline supplies were down 1.5 million barrels, while distillate stockpiles fell 1.3 million barrels last week, according to the EIA. July crude was at $48.63 a barrel on the New York Mercantile Exchange, down 38 cents, or 0.8%, from Wednesday’s settlement. Prices traded at $48.32 before the data.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

EIA reports 82 billion-cubic-foot rise in U.S. natural-gas supplies

Natural-gas futures edged higher on Thursday after the U.S. Energy Information Administration reported that supplies of the commodity rose 82 billion cubic feet for the week ended May 27. Analysts polled by S&P Global Platts forecast an increase of 85 billion cubic feet, on average. Total stocks now stand at 2.907 trillion cubic feet, up 712 billion cubic feet from a year ago and 753 billion cubic feet above the five-year average, the government said. July natural gas was up 2 cents, or 0.8%, at $2.402. It traded at $2.38 before the data.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Moleculin Biotech trading above issue price in market debut

Shares of Moleculin Biotech Inc. were trading at $7.75 Thursday morning, above the company’s issue price of $6, in the stock’s debut on the Nasdaq. The company sold 1.5 million shares to raise about $9.2 million. Moleculin had initially hoped to raise up to $12 million, according to an earlier S-1 filing. Bonwick Capital Partners and Network 1 Financial Securities underwrote the offering.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Greek bond prices fall as ECB holds off on collateral decision

Greek bond prices fell Thursday after the European Central Bank said it hasn’t decided about reintroducing a waiver that would allow the central bank to accept Greek bonds as collateral for refinancing operations. As prices fell, the yield on 10-year Greek debt rose 3 basis points to 7.35% and the yield on 2-year debt rose 8 basis points to 7.37%. A waiver would be helpful to Greek banks as that would reduce their dependence on the costlier emergency liquidity assistance program. On the equity side, the Greece Athex Composite fell 1.1% to 638.26.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News